Furusawa et al., 2023 - Google Patents
In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects …Furusawa et al., 2023
View HTML- Document ID
- 9855863702254927569
- Author
- Furusawa Y
- Kiso M
- Iida S
- Uraki R
- Hirata Y
- Imai M
- Suzuki T
- Yamayoshi S
- Kawaoka Y
- Publication year
- Publication venue
- EBioMedicine
External Links
Snippet
Summary Background The SARS-CoV-2 delta (B. 1.617. 2 lineage) variant was first identified at the end of 2020 and possessed two unique amino acid substitutions in its spike protein: S-P681R, at the S1/S2 cleavage site, and S-D950N, in the HR1 of the S2 subunit …
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Furusawa et al. | In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters | |
| Hassan et al. | A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies | |
| Liu et al. | Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant | |
| Saito et al. | Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation | |
| Rihn et al. | A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research | |
| Hassan et al. | A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques | |
| Halfmann et al. | SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters | |
| Hassan et al. | A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 | |
| Sun et al. | Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment | |
| Hui et al. | Replication of SARS-CoV-2 Omicron BA. 2 variant in ex vivo cultures of the human upper and lower respiratory tract | |
| Skariyachan et al. | Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East respiratory syndrome coronavirus infections | |
| Iwata-Yoshikawa et al. | Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways | |
| Canton et al. | MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection | |
| DiNapoli et al. | Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens | |
| Schroeder et al. | Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics | |
| Zhang et al. | A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence | |
| Zhang et al. | SARS-CoV-2 BA. 2.86 enters lung cells and evades neutralizing antibodies with high efficiency | |
| Mészáros et al. | Biology of porcine parvovirus (Ungulate parvovirus 1) | |
| Maisonnasse et al. | COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models | |
| Li et al. | SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses | |
| Ishii et al. | Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses | |
| Si et al. | Generation of a live attenuated influenza A vaccine by proteolysis targeting | |
| Richner et al. | Global mRNA degradation during lytic gammaherpesvirus infection contributes to establishment of viral latency | |
| Chouljenko et al. | Functional hierarchy of herpes simplex virus 1 viral glycoproteins in cytoplasmic virion envelopment and egress | |
| Bao et al. | Human metapneumovirus glycoprotein G disrupts mitochondrial signaling in airway epithelial cells |